A library of five hybrids and six dimers of dihydroartemisinin and artesunic acid has been synthetized in a stereo-controlled manner and evaluated for the anticancer activity against metastatic melanoma cell line (RPMI7951). Among novel derivatives, three artesunic acid dimers showed antimelanoma activity and cancer selectivity, being not toxic on normal human fibroblast (C3PV) cell line. Among the three dimers, the one bearing 4-hydroxybenzyl alcohol as a spacer showed no cytotoxic effect (CC 50 > 300 M) and high antimelanoma activity (IC 50 = 0.05 M), which was two orders of magnitude higher than that of parent artesunic acid, and of the same order of commercial drug paclitaxel. In addition, this dimer showed cancer-type selectivity towards melanoma compared to prostate (PC3) and breast (MDA-MB-231) tumors. The occurrence of a radical mechanism was hypothesized by DFO and EPR analyses. Qualitative structure activity relationships highlighted the role of artesunic acid scaffold in the control of toxicity and antimelanoma activity.

Botta, L., Cesarini, S., Zippilli, C., Filippi, S., Mattia Bizzarri, B., Baratto, M.C., et al. (2021). Stereoselective access to antimelanoma agents by hybridization and dimerization of dihydroartemisinin and artesunic acid. CHEMMEDCHEM, 16, 2270-2277 [10.1002/cmdc.202100196].

Stereoselective access to antimelanoma agents by hybridization and dimerization of dihydroartemisinin and artesunic acid

Maria Camilla Baratto;Rebecca Pogni;
2021-01-01

Abstract

A library of five hybrids and six dimers of dihydroartemisinin and artesunic acid has been synthetized in a stereo-controlled manner and evaluated for the anticancer activity against metastatic melanoma cell line (RPMI7951). Among novel derivatives, three artesunic acid dimers showed antimelanoma activity and cancer selectivity, being not toxic on normal human fibroblast (C3PV) cell line. Among the three dimers, the one bearing 4-hydroxybenzyl alcohol as a spacer showed no cytotoxic effect (CC 50 > 300 M) and high antimelanoma activity (IC 50 = 0.05 M), which was two orders of magnitude higher than that of parent artesunic acid, and of the same order of commercial drug paclitaxel. In addition, this dimer showed cancer-type selectivity towards melanoma compared to prostate (PC3) and breast (MDA-MB-231) tumors. The occurrence of a radical mechanism was hypothesized by DFO and EPR analyses. Qualitative structure activity relationships highlighted the role of artesunic acid scaffold in the control of toxicity and antimelanoma activity.
2021
Botta, L., Cesarini, S., Zippilli, C., Filippi, S., Mattia Bizzarri, B., Baratto, M.C., et al. (2021). Stereoselective access to antimelanoma agents by hybridization and dimerization of dihydroartemisinin and artesunic acid. CHEMMEDCHEM, 16, 2270-2277 [10.1002/cmdc.202100196].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1142508
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo